BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 11275921)

  • 1. Comparison of the Effects of Enoxaparin and Heparin on Inflammatory Biomarkers in Patients with ST-segment Elevated Myocardial Infarction: A prospective Open Label Pilot Clinical Trial.
    Nasiripour S; Gholami K; Mousavi S; Mohagheghi A; Radfar M; Abdollahi M; Khazaeipour Z; Mojtahedzadeh M
    Iran J Pharm Res; 2014; 13(2):583-90. PubMed ID: 25237354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of Prior Use of Four Preventive Medications on Outcomes in Patients Hospitalized for Acute Coronary Syndrome--Results from CPACS-2 Study.
    Li M; Huang Y; Du X; Li S; Ji J; Patel A; Gao R; Wu Y
    PLoS One; 2016; 11(9):e0163068. PubMed ID: 27626640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of chronic antithrombotic therapy on hospital course of patients with acute myocardial infarction.
    Bauer T; Gitt A; Zahn R; Jünger C; Koeth O; Towae F; Bestehorn K; Senges J; Zeymer U
    Clin Cardiol; 2009 Dec; 32(12):718-23. PubMed ID: 20027657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute coronary syndromes: diagnosis and management, part I.
    Kumar A; Cannon CP
    Mayo Clin Proc; 2009 Oct; 84(10):917-38. PubMed ID: 19797781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aspirin resistance: an update.
    Lancaster GI; Srinivasan J; Jain H
    Curr Atheroscler Rep; 2009 Mar; 11(2):105-10. PubMed ID: 19228483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of aspirin resistance in the treatment of acute coronary syndromes.
    Lancaster GI; Jain H; Zarich SW
    Clin Cardiol; 2008 Jan; 31(1):11-7. PubMed ID: 17803242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Primary prevention of coronary heart disease with aspirin].
    Kübler W; Darius H
    Z Kardiol; 2005; 94 Suppl 3():III/66-73. PubMed ID: 16258795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prior aspirin use and outcomes in elderly patients hospitalized with acute myocardial infarction.
    Portnay EL; Foody JM; Rathore SS; Wang Y; Masoudi FA; Curtis JP; Krumholz HM
    J Am Coll Cardiol; 2005 Sep; 46(6):967-74. PubMed ID: 16168277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk Stratification in Patients with Unstable Angina and Non-ST-elevation Myocardial Infarction.
    Desai AS; Stone PH
    Curr Treat Options Cardiovasc Med; 2004 Feb; 6(1):3-14. PubMed ID: 15023280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low molecular weight heparins in the management of unstable angina/non-Q-wave myocardial infarction.
    Cohen M
    Semin Thromb Hemost; 1999; 25 Suppl 3():113-21. PubMed ID: 10549726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enoxaparin for the treatment of acute myocardial infarction with persistent ST-segment elevation.
    Rubboli A; Herzfeld I; Maresta A
    Minerva Cardioangiol; 2003 Oct; 51(5):463-70, 470-4. PubMed ID: 14551516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prior aspirin users with acute non-ST-elevation coronary syndromes are at increased risk of cardiac events and benefit from enoxaparin.
    Santopinto J; Gurfinkel EP; Torres V; Marcos E; Bozovich GE; Mautner B; McCabe CH; Antman EM
    Am Heart J; 2001 Apr; 141(4):566-72. PubMed ID: 11275921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and efficacy of unfractionated heparin versus enoxaparin in patients who are obese and patients with severe renal impairment: analysis from the ESSENCE and TIMI 11B studies.
    Spinler SA; Inverso SM; Cohen M; Goodman SG; Stringer KA; Antman EM;
    Am Heart J; 2003 Jul; 146(1):33-41. PubMed ID: 12851605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of enoxaparin versus unfractionated heparin in patients with ST-segment elevation myocardial infarction also treated with clopidogrel.
    Sabatine MS; Morrow DA; Dalby A; Pfisterer M; Duris T; Lopez-Sendon J; Murphy SA; Gao R; Antman EM; Braunwald E;
    J Am Coll Cardiol; 2007 Jun; 49(23):2256-63. PubMed ID: 17560290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of low-molecular-weight heparin with unfractionated heparin for unstable coronary artery disease. Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q-Wave Coronary Events Study Group.
    Cohen M; Demers C; Gurfinkel EP; Turpie AG; Fromell GJ; Goodman S; Langer A; Califf RM; Fox KA; Premmereur J; Bigonzi F
    N Engl J Med; 1997 Aug; 337(7):447-52. PubMed ID: 9250846
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.